Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Personalized medicine in oncology: next generation

Nature Reviews Drug Discovery volume 10, pages 895–896 (2011)Cite this article

Subjects

Managing complexity and risk

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Figure 1: Novel biomarker launch: issue map.

References

  1. Khleif, S. M. et al. AACR-FDA-NCI cancer biomarkers collaborative consensus report: advancing the use of biomarkers in cancer drug development. Clin. Cancer Res. 16, 3299–3318 (2010).

    CAS  Article  PubMed  Google Scholar 

  2. US Food and Drug Administration. Drug–Diagnostic Co-development Concept Paper — Draft. FDA website [online], (2005).

  3. Kwak, E. L. et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363, 1693–1703 (2010).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Davsi, J. C. et al. The microeconomics of personalized medicine: today's challenge and tomorrow's promise. Nature Rev. Drug Discov. 8, 279–286 (2009).

    Article  Google Scholar 

  5. Million, Ryan P. Impact of genetic diagnostics on drug development strategy. Nature Rev. Drug Discov. 5, 459–462 (2006).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Alex Chiang and Ryan P. Million are at 675 Third Ave., 20th floor, New York 10017, New York, USA ,

    Alex Chiang & Ryan P. Million

Authors
  1. Alex Chiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan P. Million
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Alex Chiang or Ryan P. Million.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information S1

Projected sales of Xalkori and Zelboraf (millions of US dollars). (PDF 438 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chiang, A., Million, R. Personalized medicine in oncology: next generation. Nat Rev Drug Discov 10, 895–896 (2011). https://doi.org/10.1038/nrd3603

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3603

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing